Risk stratification of prostate cancer in the modern era.
about
Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune DiseasesVirus encoded circulatory miRNAs for early detection of prostate cancerPerformance characteristics of prostate-specific antigen density and biopsy core details to predict oncological outcome in patients with intermediate to high-risk prostate cancer underwent robot-assisted radical prostatectomy.Novel potential serological prostate cancer biomarkers using CT100+ cancer antigen microarray platform in a multi-cultural South African cohort.Approaches to the discovery of non-invasive urinary biomarkers of prostate cancer
P2860
Risk stratification of prostate cancer in the modern era.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Risk stratification of prostate cancer in the modern era.
@ast
Risk stratification of prostate cancer in the modern era.
@en
type
label
Risk stratification of prostate cancer in the modern era.
@ast
Risk stratification of prostate cancer in the modern era.
@en
prefLabel
Risk stratification of prostate cancer in the modern era.
@ast
Risk stratification of prostate cancer in the modern era.
@en
P2860
P1476
Risk stratification of prostate cancer in the modern era.
@en
P2093
Andrew S Behesnilian
Robert E Reiter
P2860
P304
P356
10.1097/MOU.0000000000000164
P577
2015-05-01T00:00:00Z